ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Steve K. Singh
Gilbert H.L. Tang
William G. Williams
Tirone E. David
Michael A. Borger
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Singh, S. K.
Right arrow Articles by Borger, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Singh, S. K.
Right arrow Articles by Borger, M. A.
Related Collections
Right arrow Valve disease

Ann Thorac Surg 2006;82:1735-1741
© 2006 The Society of Thoracic Surgeons


Original Articles: Cardiovascular

Midterm Outcomes of Tricuspid Valve Repair Versus Replacement for Organic Tricuspid Disease

Steve K. Singh, MDa, Gilbert H.L. Tang, MDa, Manjula D. Maganti, MSb, Susan Armstrong, MSb, William G. Williams, MDa,c, Tirone E. David, MDa,b, Michael A. Borger, MD, PhDa,b,*

a Divisions of Cardiac Surgery of the University of Toronto, Toronto, Ontario, Canada
b Toronto General Hospital, Toronto, Ontario, Canada
c The Hospital for Sick Children, Toronto, Ontario, Canada

Accepted for publication June 2, 2006.

* Address correspondence to Dr Borger, Toronto General Hospital, Room 4N-451, 200 Elizabeth Street, Toronto, Ontario, Canada M5G 2C4 (Email: michael.borger{at}uhn.on.ca).

Presented at the Forty-second Annual Meeting of The Society of Thoracic Surgeons, Chicago, IL, Jan 30–Feb 1, 2006.

BACKGROUND: Organic tricuspid valve (TV) disease is uncommon. Few studies have compared TV repair with replacement in these patients. The current study compared midterm outcomes of TV repair versus replacement in a large group of patients with organic tricuspid disease.

METHODS: Two-hundred and fifty patients underwent surgery for organic TV disease at our institution from 1979 to 2003. Clinical and echocardiographic follow-up were obtained, were 99% complete, and were 5.2 ± 4.1 years long (mean ± standard deviation).

RESULTS: One hundred and seventy-eight patients (71%) underwent TV repair and 72 (29%) received TV replacement (54 bioprosthetic, 18 mechanical). Repair patients were more likely to have hypertension, rheumatic pathology, or elective surgery. Concomitant procedures included mitral (50% of patients), aortic (26%), and coronary bypass (6%) operations. Perioperative and midterm mortality were higher in the replacement group (both p < 0.001). Cox regression analysis revealed TV replacement as an independent predictor of midterm mortality (hazard ratio: 5.1, 95% confidence interval: 2.9 to 9.1, p < 0.001) and decreased event-free survival (hazard ratio: 2.0, 95% confidence interval: 1.1 to 3.6, p = 0.02). Follow-up echocardiography revealed more moderate to severe tricuspid regurgitation in repair patients (38% vs 5%, p < 0.001), but no difference in New York Heart Association functional class or reoperation rates.

CONCLUSIONS: Tricuspid valve repair is associated with better perioperative, midterm, and event-free survival than TV replacement in patients with organic tricuspid disease. Despite more tricuspid regurgitation in the repair group during follow-up, reoperation rates and functional class were similar. Repair should be performed whenever possible in patients with organic tricuspid disease.




This article has been cited by other articles:


Home page
Eur. J. Cardiothorac. Surg.Home page
T. Guenther, C. Noebauer, D. Mazzitelli, R. Busch, P. Tassani-Prell, and R. Lange
Tricuspid valve surgery: a thirty-year assessment of early and late outcome
Eur. J. Cardiothorac. Surg., August 1, 2008; 34(2): 402 - 409.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. M. Bernal, A. Ponton, B. Diaz, J. Llorca, I. Garcia, A. Sarralde, C. Diago, and J. M. Revuelta
Surgery for rheumatic tricuspid valve disease: a 30-year experience.
J. Thorac. Cardiovasc. Surg., August 1, 2008; 136(2): 476 - 481.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. H. Jones
The Year in Cardiovascular Surgery
J. Am. Coll. Cardiol., May 8, 2007; 49(18): 1887 - 1898.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2006 by The Society of Thoracic Surgeons.